Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia

ClinicalTrials.gov ID: NCT03485053

Public ClinicalTrials.gov record NCT03485053. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

2 Part, Phase II Study of Intravenous, Single Ascending Dose Administrations of IOP Injection in Patients With Iron Deficient Anemia

Study identification

NCT ID
NCT03485053
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
MegaPro Biomedical Co. Ltd.
Industry
Enrollment
49 participants

Conditions and interventions

Interventions

  • IOP Injection / MPB-1514 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 28, 2018
Primary completion
Sep 29, 2020
Completion
Aug 30, 2021
Last update posted
Oct 27, 2021

2018 – 2021

United States locations

U.S. sites
8
U.S. states
5
U.S. cities
8
Facility City State ZIP Site status
North America Research Institute Azusa California 91702
Valley Renal Medical Group Northridge California 91324
Whittier Internal Medicine and Nephrology Medical Group Whittier California 90602
South Florida Research Institute Lauderdale Lakes Florida 33313
North Shore University Hospital Lab Manhasset New York 11030
Clinical Research Development Associates Springfield Gardens New York 11413
Northeast Clinical Research Center Bethlehem Pennsylvania 18017
Southwest Houston Research Ltd. San Antonio Texas 78227

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03485053, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 27, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03485053 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →